Global Bioprocesing Equipment Market - 2025 -2033
Bioprocessing Equipment Market Size& Industry Outlook
The global bioprocessing equipment market size reached US$ 58.14billion with rise of US$63.45billion in 2024 is expected to reach US$ 147.55billion by 2033, growing at a CAGR of 9.9%during the forecast period 2025-2033.
One major driver of the global bioprocessing equipment market, is the shift toward continuous bioprocessing. Unlike traditional batch methods, continuous processing improves efficiency, reduces production costs, and enhances product consistency. For instance, in monoclonal antibody (mAb) manufacturing, companies adopting continuous chromatography systems can achieve higher yields with smaller equipment footprints, allowing faster scale-up and better flexibility. This shift is encouraging both established biopharma companies and contract manufacturing organizations (CMOs) to invest heavily in advanced equipment designed to support continuous operations.
Key Highlights
Drivers: Growing demand for biopharmaceutical production is significantly driving the bioprocessing equipment market growth
The global bioprocessing equipment market is driven by the increasing demand for biopharmaceutical production, driven by the expansion of biologics pipelines in therapeutic areas like oncology, autoimmune diseases, and rare genetic disorders. Biologics, such as monoclonal antibodies, recombinant proteins, vaccines, and advanced cell and gene therapies, are preferred due to their precision and higher efficacy. This shift in manufacturing capabilities is fueling demand for advanced bioreactors, filtration systems, chromatography units, and single-use technologies.
For instance, in April 2025, Wuxi Biologics completed its first commercial Process Performance Qualification (PPQ) campaign for its three 5,000 L single-use bioreactors at its MFG20 facility in Hangzhou. These are Asia’s first reactors in a 15,000-L configuration using single-use technology. The upgrade increased capacity at MFG20 from 8,000 L to 23,000 L by combining the new 5,000 L units with existing 2,000 L reactor.
Restraints: Stringent regulatory compliance requirements are hampering the growth of the bioprocessing equipment market
The global bioprocessing equipment market faces significant challenges due to stringent regulatory compliance requirements from agencies like the FDA and EMA. These standards ensure product safety, consistency, and quality in bioprocessing equipment used in biologics, vaccines, and cell and gene therapies. Meeting these standards requires extensive validation, documentation, and inspections, increasing time-to-market and cost for manufacturers. Smaller biotech firms and new entrants face even greater difficulties, as regulatory hurdles can limit their ability to adopt innovative equipment quickly. This complex regulatory environment, essential for patient safety, acts as a bottleneck for innovation and scaling in the bioprocessing equipment market.
Segmentation Analysis
The global bioprocessing equipment market is segmented based onproduct type, process, application, end user, and region.
Product Type:
The bioreactors from Product Type segment to dominate the Bioprocessing Equipment market with a 35.3% share in 2024
The bioreactors segment is being driven by the rising need for scalable, flexible, and efficient production systems to support the growing pipeline of biologics, including monoclonal antibodies, recombinant proteins, and cell and gene therapies. The shift toward single-use bioreactors has further accelerated growth, as they offer reduced risk of contamination, lower cleaning costs, and faster turnaround between production runs. Additionally, continuous innovations such as automated control systems, perfusion-enabled bioreactors, and hybrid stainless steel–disposable modular allowing manufacturers to enhance yield and maintain product consistency, making bioreactors a cornerstone of modern bioprocessing.
For instance, in April 2025, Thermo Fisher Scientific has introduced the 5L DynaDrive Single-Use Bioreactor, a new addition to its bioreactor portfolio. This innovative device offers scalability from 1 to 5,000 liters, accelerates bench-scale process development, and facilitates a cost-effective transition from bench to commercialization, ensuring consistent reactor design and film across all scales.
Application: The vaccines segment is estimated to have a 41.2% of the bioprocessing equipment market share in 2024
The vaccines segment is being fueled by the global focus on preventive healthcare and preparedness for infectious disease outbreaks, as seen during the COVID-19 pandemic. Rising demand for mRNA vaccines, viral vector-based vaccines, and recombinant protein vaccines is creating significant pressure on manufacturers to expand capacity, which in turn drives investment in advanced bioprocessing equipment. Governments and international health organizations are also increasing funding to boost vaccine R&D and production infrastructure, particularly in emerging markets. This trend is further supported by the move toward personalized and therapeutic vaccines, requiring flexible equipment that can handle diverse vaccine platforms efficiently.
Geographical Analysis
North America dominates the global bioprocessing equipment market with a 43.5% in 2024
North America dominates the global bioprocessing equipment market due to its biopharmaceutical manufacturers, advanced research infrastructure, and early adoption of innovative technologies. The region benefits from rising biologic demand and continuous investments by leading players like Thermo Fisher Scientific and Danaher. CDMOs support outsourcing trends, boosting equipment sales.
The U.S. is the core growth driver in North America, supported by the highest number of FDA-approved biologics and cell and gene therapies globally. Growing investments by companies such as Sartorius, Moderna, and WuXi Biologics USA in expanding biomanufacturing facilities fuel the need for scalable and flexible equipment. Government programs focused on pandemic preparedness and vaccine capacity also continue to drive the market forward.
For instance, in November 2024, Sartorius Stedim Biotech has opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts, aiming to promote collaboration, co-development, and learning among customers and external innovation partners, utilizing Sartorius' latest technologies in real-life bioprocess workflows.
Europe is the second region after North America which is expected to dominate the global bioprocessing equipment market with a 34.5% in 2024
Europe is driven by its well-regulated biopharma landscape, high standards for quality manufacturing, and focus on biosimilars and vaccines. Countries like Switzerland, France, and the U.K. host major biotech clusters, making the region an important hub for innovation. The adoption of single-use systems, automation, and continuous bioprocessing is rising steadily as companies look to optimize production efficiency and reduce costs.
Germany stands out in Europe due to its strong manufacturing base and world-leading biotech companies like Sartorius and Merck KGaA, which are continuously innovating in bioprocessing solutions. The government’s support for biotech R&D and initiatives in vaccine development and regenerative medicine enhance equipment demand. Germany’s focus on expanding capacity for monoclonal antibodies and cell therapy production makes it a key growth engine in the region.
For instance, in March 2025, Sartorius, a German pharmaceutical and laboratory equipment supplier, plans to invest in a new production line for pallet tanks used in single-use bioreactors at its Bengaluru R&D facility until 2027 to meet local and global demands.
The Asia Pacific region is the fastest-growing region in the global bioprocessing equipment market, with a CAGR of 8.1% in 2024
Asia Pacific is experiencing rapid growth as countries like China, South Korea, and India emerge as leading hubs for biologics and biosimilar manufacturing. The region benefits from lower production costs, government support for domestic biopharma, and increasing foreign investments by CDMOs. Rising healthcare needs and a growing patient population are also encouraging adoption of advanced bioprocessing equipment for large-scale vaccine and biologics production.
Japan’s market is primarily driven by its focus on regenerative medicine, stem cell research, and gene therapies, supported by favorable policies such as fast-track approval pathways. Local companies are adopting closed, automated bioprocessing systems to ensure efficiency and compliance for advanced therapies. The government’s consistent funding and collaborations with global biopharma players are accelerating demand for next-generation equipment.
For instance, in April 2025, Asahi Kasei, a Japan-based pharmaceutical company, has restructured its bioprocess businesses to provide more agile services, deep innovation in bioprocess solutions, and stronger support in emerging modalities, in response to growing pharmaceutical industry demand.
Competitive Landscape
Top companies in the bioprocessing equipment market include Thermo Fisher Scientific, Inc., Sartorius AG, Danaher Corporation (Cytiva), Merck KGaA, Eppendorf, Bionet, Solaris Biotech, PBS Biotech, Inc., Applikon Biotechnology (Getinge / Applikon), Celartia and among others.
Thermo Fisher Scientific, Inc :Allergan Plc is a leading global brand in the Bioprocessing Equipment market, known for its innovative treatments that address both medical and cosmetic aspects of acne management. With a strong global distribution network and strategic marketing initiatives, Allergan expands access to acne solutions across multiple regions. The company's expertise in developing advanced formulations and combination therapies has enhanced treatment effectiveness and improved patient adherence.
The global bioprocessing equipment market report delivers a detailed analysis with 62 key tables, more than 57visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.
The global bioprocessing equipment market size reached US$ 58.14billion with rise of US$63.45billion in 2024 is expected to reach US$ 147.55billion by 2033, growing at a CAGR of 9.9%during the forecast period 2025-2033.
One major driver of the global bioprocessing equipment market, is the shift toward continuous bioprocessing. Unlike traditional batch methods, continuous processing improves efficiency, reduces production costs, and enhances product consistency. For instance, in monoclonal antibody (mAb) manufacturing, companies adopting continuous chromatography systems can achieve higher yields with smaller equipment footprints, allowing faster scale-up and better flexibility. This shift is encouraging both established biopharma companies and contract manufacturing organizations (CMOs) to invest heavily in advanced equipment designed to support continuous operations.
Key Highlights
- North America dominates the bioprocessing equipment market with the largest revenue share of 43.5% in 2024.
- The Asia Pacific is the fastest-growing region and is expected to grow at the fastest CAGR of8.1% over the forecast period.
- Based on product type, bioreactors segmented the market with the largest revenue share of 35.3% in 2024.
- The major market players in the Thermo Fisher Scientific, Inc, Sartorius AG, Danaher Corporation (Cytiva), Merck KGaA, Eppendorf, Bionet, Solaris Biotech, PBS Biotech, Inc., Applikon Biotechnology(Getinge / Applikon), Celartia and among others.
Drivers: Growing demand for biopharmaceutical production is significantly driving the bioprocessing equipment market growth
The global bioprocessing equipment market is driven by the increasing demand for biopharmaceutical production, driven by the expansion of biologics pipelines in therapeutic areas like oncology, autoimmune diseases, and rare genetic disorders. Biologics, such as monoclonal antibodies, recombinant proteins, vaccines, and advanced cell and gene therapies, are preferred due to their precision and higher efficacy. This shift in manufacturing capabilities is fueling demand for advanced bioreactors, filtration systems, chromatography units, and single-use technologies.
For instance, in April 2025, Wuxi Biologics completed its first commercial Process Performance Qualification (PPQ) campaign for its three 5,000 L single-use bioreactors at its MFG20 facility in Hangzhou. These are Asia’s first reactors in a 15,000-L configuration using single-use technology. The upgrade increased capacity at MFG20 from 8,000 L to 23,000 L by combining the new 5,000 L units with existing 2,000 L reactor.
Restraints: Stringent regulatory compliance requirements are hampering the growth of the bioprocessing equipment market
The global bioprocessing equipment market faces significant challenges due to stringent regulatory compliance requirements from agencies like the FDA and EMA. These standards ensure product safety, consistency, and quality in bioprocessing equipment used in biologics, vaccines, and cell and gene therapies. Meeting these standards requires extensive validation, documentation, and inspections, increasing time-to-market and cost for manufacturers. Smaller biotech firms and new entrants face even greater difficulties, as regulatory hurdles can limit their ability to adopt innovative equipment quickly. This complex regulatory environment, essential for patient safety, acts as a bottleneck for innovation and scaling in the bioprocessing equipment market.
Segmentation Analysis
The global bioprocessing equipment market is segmented based onproduct type, process, application, end user, and region.
Product Type:
The bioreactors from Product Type segment to dominate the Bioprocessing Equipment market with a 35.3% share in 2024
The bioreactors segment is being driven by the rising need for scalable, flexible, and efficient production systems to support the growing pipeline of biologics, including monoclonal antibodies, recombinant proteins, and cell and gene therapies. The shift toward single-use bioreactors has further accelerated growth, as they offer reduced risk of contamination, lower cleaning costs, and faster turnaround between production runs. Additionally, continuous innovations such as automated control systems, perfusion-enabled bioreactors, and hybrid stainless steel–disposable modular allowing manufacturers to enhance yield and maintain product consistency, making bioreactors a cornerstone of modern bioprocessing.
For instance, in April 2025, Thermo Fisher Scientific has introduced the 5L DynaDrive Single-Use Bioreactor, a new addition to its bioreactor portfolio. This innovative device offers scalability from 1 to 5,000 liters, accelerates bench-scale process development, and facilitates a cost-effective transition from bench to commercialization, ensuring consistent reactor design and film across all scales.
Application: The vaccines segment is estimated to have a 41.2% of the bioprocessing equipment market share in 2024
The vaccines segment is being fueled by the global focus on preventive healthcare and preparedness for infectious disease outbreaks, as seen during the COVID-19 pandemic. Rising demand for mRNA vaccines, viral vector-based vaccines, and recombinant protein vaccines is creating significant pressure on manufacturers to expand capacity, which in turn drives investment in advanced bioprocessing equipment. Governments and international health organizations are also increasing funding to boost vaccine R&D and production infrastructure, particularly in emerging markets. This trend is further supported by the move toward personalized and therapeutic vaccines, requiring flexible equipment that can handle diverse vaccine platforms efficiently.
Geographical Analysis
North America dominates the global bioprocessing equipment market with a 43.5% in 2024
North America dominates the global bioprocessing equipment market due to its biopharmaceutical manufacturers, advanced research infrastructure, and early adoption of innovative technologies. The region benefits from rising biologic demand and continuous investments by leading players like Thermo Fisher Scientific and Danaher. CDMOs support outsourcing trends, boosting equipment sales.
The U.S. is the core growth driver in North America, supported by the highest number of FDA-approved biologics and cell and gene therapies globally. Growing investments by companies such as Sartorius, Moderna, and WuXi Biologics USA in expanding biomanufacturing facilities fuel the need for scalable and flexible equipment. Government programs focused on pandemic preparedness and vaccine capacity also continue to drive the market forward.
For instance, in November 2024, Sartorius Stedim Biotech has opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts, aiming to promote collaboration, co-development, and learning among customers and external innovation partners, utilizing Sartorius' latest technologies in real-life bioprocess workflows.
Europe is the second region after North America which is expected to dominate the global bioprocessing equipment market with a 34.5% in 2024
Europe is driven by its well-regulated biopharma landscape, high standards for quality manufacturing, and focus on biosimilars and vaccines. Countries like Switzerland, France, and the U.K. host major biotech clusters, making the region an important hub for innovation. The adoption of single-use systems, automation, and continuous bioprocessing is rising steadily as companies look to optimize production efficiency and reduce costs.
Germany stands out in Europe due to its strong manufacturing base and world-leading biotech companies like Sartorius and Merck KGaA, which are continuously innovating in bioprocessing solutions. The government’s support for biotech R&D and initiatives in vaccine development and regenerative medicine enhance equipment demand. Germany’s focus on expanding capacity for monoclonal antibodies and cell therapy production makes it a key growth engine in the region.
For instance, in March 2025, Sartorius, a German pharmaceutical and laboratory equipment supplier, plans to invest in a new production line for pallet tanks used in single-use bioreactors at its Bengaluru R&D facility until 2027 to meet local and global demands.
The Asia Pacific region is the fastest-growing region in the global bioprocessing equipment market, with a CAGR of 8.1% in 2024
Asia Pacific is experiencing rapid growth as countries like China, South Korea, and India emerge as leading hubs for biologics and biosimilar manufacturing. The region benefits from lower production costs, government support for domestic biopharma, and increasing foreign investments by CDMOs. Rising healthcare needs and a growing patient population are also encouraging adoption of advanced bioprocessing equipment for large-scale vaccine and biologics production.
Japan’s market is primarily driven by its focus on regenerative medicine, stem cell research, and gene therapies, supported by favorable policies such as fast-track approval pathways. Local companies are adopting closed, automated bioprocessing systems to ensure efficiency and compliance for advanced therapies. The government’s consistent funding and collaborations with global biopharma players are accelerating demand for next-generation equipment.
For instance, in April 2025, Asahi Kasei, a Japan-based pharmaceutical company, has restructured its bioprocess businesses to provide more agile services, deep innovation in bioprocess solutions, and stronger support in emerging modalities, in response to growing pharmaceutical industry demand.
Competitive Landscape
Top companies in the bioprocessing equipment market include Thermo Fisher Scientific, Inc., Sartorius AG, Danaher Corporation (Cytiva), Merck KGaA, Eppendorf, Bionet, Solaris Biotech, PBS Biotech, Inc., Applikon Biotechnology (Getinge / Applikon), Celartia and among others.
Thermo Fisher Scientific, Inc :Allergan Plc is a leading global brand in the Bioprocessing Equipment market, known for its innovative treatments that address both medical and cosmetic aspects of acne management. With a strong global distribution network and strategic marketing initiatives, Allergan expands access to acne solutions across multiple regions. The company's expertise in developing advanced formulations and combination therapies has enhanced treatment effectiveness and improved patient adherence.
The global bioprocessing equipment market report delivers a detailed analysis with 62 key tables, more than 57visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Process
2.5. Snippet by Application
2.6. Snippet by End User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Growing Demand for Biopharmaceutical Production
3.1.1.2. Increasing Adoption of Single-Use Technologies
3.1.2. Restraints
3.1.2.1. Stringent Regulatory Compliance Requirements
3.1.2.2. High Cost of Advanced Equipment
3.1.3. Opportunity
3.1.3.1. Rising Investments in Cell and Gene Therapy
3.1.3.2. Expansion of Bioprocessing Facilities in Emerging Markets
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with the Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. Unmet Needs and Gaps
4.7. Recommended Strategies for Market Entry and Expansion
4.8. Pricing Analysis and Price Dynamics
5. BIOPROCESSING EQUIPMENT MARKET, BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Bioreactors*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Filtration Systems
5.4. Chromatography Systems
5.5. Cell Culture Systems
5.6. Mixing Systems
5.7. Control & Monitoring Systems
5.8. Others
6. BIOPROCESSING EQUIPMENT MARKET, BY PROCESS
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
6.1.2. Market Attractiveness Index, By Process
6.2. Upstream Processing*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Downstream Processing
7. BIOPROCESSING EQUIPMENT MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Vaccines*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Gene & Cell Therapy
7.4. Monoclonal Antibodies (mAbs)
7.5. Recombinant Proteins
7.6. Others
8. BIOPROCESSING EQUIPMENT MARKET, BY END USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Biopharmaceutical Companies*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Contract Manufacturing Organizations (CMOs)
8.4. Academic & Research Institutes
9. BIOPROCESSING EQUIPMENT MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. UK
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. China
9.4.7.2. India
9.4.7.3. Japan
9.4.7.4. South Korea
9.4.7.5. Rest of Asia-Pacific
9.5. South America
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. Brazil
9.5.7.2. Argentina
9.5.7.3. Rest of South America
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Thermo Fisher Scientific, Inc*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. Sartorius AG
11.3. Danaher Corporation (Cytiva)
11.4. Merck KGaA
11.5. Eppendorf
11.6. Bionet
11.7. Solaris Biotech
11.8. PBS Biotech, Inc.
11.9. Applikon Biotechnology (Getinge / Applikon)
11.10. Cellaria ( LIST NOT EXHAUSTIVE )
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Process
2.5. Snippet by Application
2.6. Snippet by End User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Growing Demand for Biopharmaceutical Production
3.1.1.2. Increasing Adoption of Single-Use Technologies
3.1.2. Restraints
3.1.2.1. Stringent Regulatory Compliance Requirements
3.1.2.2. High Cost of Advanced Equipment
3.1.3. Opportunity
3.1.3.1. Rising Investments in Cell and Gene Therapy
3.1.3.2. Expansion of Bioprocessing Facilities in Emerging Markets
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with the Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. Unmet Needs and Gaps
4.7. Recommended Strategies for Market Entry and Expansion
4.8. Pricing Analysis and Price Dynamics
5. BIOPROCESSING EQUIPMENT MARKET, BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Bioreactors*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Filtration Systems
5.4. Chromatography Systems
5.5. Cell Culture Systems
5.6. Mixing Systems
5.7. Control & Monitoring Systems
5.8. Others
6. BIOPROCESSING EQUIPMENT MARKET, BY PROCESS
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
6.1.2. Market Attractiveness Index, By Process
6.2. Upstream Processing*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Downstream Processing
7. BIOPROCESSING EQUIPMENT MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Vaccines*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Gene & Cell Therapy
7.4. Monoclonal Antibodies (mAbs)
7.5. Recombinant Proteins
7.6. Others
8. BIOPROCESSING EQUIPMENT MARKET, BY END USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Biopharmaceutical Companies*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Contract Manufacturing Organizations (CMOs)
8.4. Academic & Research Institutes
9. BIOPROCESSING EQUIPMENT MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. UK
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. China
9.4.7.2. India
9.4.7.3. Japan
9.4.7.4. South Korea
9.4.7.5. Rest of Asia-Pacific
9.5. South America
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. Brazil
9.5.7.2. Argentina
9.5.7.3. Rest of South America
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Thermo Fisher Scientific, Inc*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. Sartorius AG
11.3. Danaher Corporation (Cytiva)
11.4. Merck KGaA
11.5. Eppendorf
11.6. Bionet
11.7. Solaris Biotech
11.8. PBS Biotech, Inc.
11.9. Applikon Biotechnology (Getinge / Applikon)
11.10. Cellaria ( LIST NOT EXHAUSTIVE )
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
LIST OF TABLES
Table 1 Global Bioprocessing Equipment Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Bioprocessing Equipment Market Value, By Process, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Bioprocessing Equipment Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Bioprocessing Equipment Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Bioprocessing Equipment Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Bioprocessing Equipment Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 8 Global Bioprocessing Equipment Market Value, By Process, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 10 Global Bioprocessing Equipment Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 12 Global Bioprocessing Equipment Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 14 Global Bioprocessing Equipment Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Bioprocessing Equipment Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 17 North America Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 18 North America Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 North America Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 20 North America Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Europe Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 23 Europe Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 24 Europe Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 25 Europe Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 29 Asia-Pacific Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 30 Asia-Pacific Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 32 South America Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 33 South America Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 34 South America Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 35 South America Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Thermo Fisher Scientific, Inc.: Overview
Table 42 Thermo Fisher Scientific, Inc.: Product Portfolio
Table 43 Thermo Fisher Scientific, Inc.: Key Developments
Table 44 Sartorius AG: Overview
Table 45 Sartorius AG: Product Portfolio
Table 46 Sartorius AG: Key Developments
Table 47 Danaher Corporation (Cytiva): Overview
Table 48 Danaher Corporation (Cytiva): Product Portfolio
Table 49 Danaher Corporation (Cytiva): Key Developments
Table 50 Merck KGaA: Overview
Table 51 Merck KGaA: Product Portfolio
Table 52 Merck KGaA: Key Developments
Table 53 Eppendorf: Overview
Table 54 Eppendorf: Product Portfolio
Table 55 Eppendorf: Key Developments
Table 56 Bionet: Overview
Table 57 Bionet: Product Portfolio
Table 58 Bionet: Key Developments
Table 59 Solaris Biotech: Overview
Table 60 Solaris Biotech: Product Portfolio
Table 61 Solaris Biotech: Key Developments
Table 62 PBS Biotech, Inc.: Overview
Table 63 PBS Biotech, Inc.: Product Portfolio
Table 64 PBS Biotech, Inc.: Key Developments
Table 65 Applikon Biotechnology (Getinge / Applikon): Overview
Table 66 Applikon Biotechnology (Getinge / Applikon): Product Portfolio
Table 67 Applikon Biotechnology (Getinge / Applikon): Key Developments
Table 68 Celartia: Overview
Table 69 Celartia: Product Portfolio
Table 70 Celartia: Key Developments
Table 1 Global Bioprocessing Equipment Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Bioprocessing Equipment Market Value, By Process, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Bioprocessing Equipment Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Bioprocessing Equipment Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Bioprocessing Equipment Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Bioprocessing Equipment Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 8 Global Bioprocessing Equipment Market Value, By Process, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 10 Global Bioprocessing Equipment Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 12 Global Bioprocessing Equipment Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 14 Global Bioprocessing Equipment Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Bioprocessing Equipment Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 17 North America Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 18 North America Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 North America Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 20 North America Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Europe Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 23 Europe Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 24 Europe Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 25 Europe Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 29 Asia-Pacific Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 30 Asia-Pacific Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 32 South America Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 33 South America Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 34 South America Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 35 South America Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Bioprocessing Equipment Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Bioprocessing Equipment Market Value, By Process, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Bioprocessing Equipment Market Value, By Application, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Bioprocessing Equipment Market Value, By End User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Bioprocessing Equipment Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Thermo Fisher Scientific, Inc.: Overview
Table 42 Thermo Fisher Scientific, Inc.: Product Portfolio
Table 43 Thermo Fisher Scientific, Inc.: Key Developments
Table 44 Sartorius AG: Overview
Table 45 Sartorius AG: Product Portfolio
Table 46 Sartorius AG: Key Developments
Table 47 Danaher Corporation (Cytiva): Overview
Table 48 Danaher Corporation (Cytiva): Product Portfolio
Table 49 Danaher Corporation (Cytiva): Key Developments
Table 50 Merck KGaA: Overview
Table 51 Merck KGaA: Product Portfolio
Table 52 Merck KGaA: Key Developments
Table 53 Eppendorf: Overview
Table 54 Eppendorf: Product Portfolio
Table 55 Eppendorf: Key Developments
Table 56 Bionet: Overview
Table 57 Bionet: Product Portfolio
Table 58 Bionet: Key Developments
Table 59 Solaris Biotech: Overview
Table 60 Solaris Biotech: Product Portfolio
Table 61 Solaris Biotech: Key Developments
Table 62 PBS Biotech, Inc.: Overview
Table 63 PBS Biotech, Inc.: Product Portfolio
Table 64 PBS Biotech, Inc.: Key Developments
Table 65 Applikon Biotechnology (Getinge / Applikon): Overview
Table 66 Applikon Biotechnology (Getinge / Applikon): Product Portfolio
Table 67 Applikon Biotechnology (Getinge / Applikon): Key Developments
Table 68 Celartia: Overview
Table 69 Celartia: Product Portfolio
Table 70 Celartia: Key Developments
LIST OF FIGURES
Figure 1 Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 4 Global Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 6 Global Bioprocessing Equipment Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Bioprocessing Equipment Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Bioreactors Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 9 Filtration Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 10 Chromatography Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 11 Cell Culture Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 12 Mixing Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 13 Control & Monitoring Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 14 Others Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 15 Global Bioprocessing Equipment Market Y-o-Y Growth, By Process, 2023-2033 (%)
Figure 16 Upstream Processing Process in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 17 Downstream Processing Process in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 18 Global Bioprocessing Equipment Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 19 Vaccines Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 20 Gene & Cell Therapy Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 21 Monoclonal Antibodies (mAbs) Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 22 Recombinant Proteins Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 23 Others Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 24 Global Bioprocessing Equipment Market Y-o-Y Growth, By End User, 2023-2033 (%)
Figure 25 Biopharmaceutical Companies End User in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 26 Contract Manufacturing Organizations (CMOs) End User in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 27 Academic & Research Institutes End User in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 28 Global Bioprocessing Equipment Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 29 North America Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 30 North America Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 31 North America Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 32 North America Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 33 North America Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 34 North America Bioprocessing Equipment Market Share, By Country, 2024 & 2033 (%)
Figure 35 Europe Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 36 Europe Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 37 Europe Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 38 Europe Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 39 Europe Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 40 Europe Bioprocessing Equipment Market Share, By Country, 2024 & 2033 (%)
Figure 41 Asia-Pacific Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 42 Asia-Pacific Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 43 Asia-Pacific Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 44 Asia-Pacific Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 45 Asia-Pacific Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 46 Asia-Pacific Bioprocessing Equipment Market Share, By Country, 2024 & 2033 (%)
Figure 47 South America Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 48 South America Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 49 South America Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 50 South America Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 51 South America Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 52 South America Bioprocessing Equipment Market Share, By Country, 2024 & 2033 (%)
Figure 53 Middle East and Africa Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 54 Middle East and Africa Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 55 Middle East and Africa Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 56 Middle East and Africa Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 57 Middle East and Africa Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 58 Thermo Fisher Scientific, Inc.: Financials
Figure 59 Sartorius AG: Financials
Figure 60 Danaher Corporation (Cytiva): Financials
Figure 61 Merck KGaA: Financials
Figure 62 Eppendorf: Financials
Figure 63 Bionet: Financials
Figure 64 Solaris Biotech: Financials
Figure 65 PBS Biotech, Inc.: Financials
Figure 66 Applikon Biotechnology (Getinge / Applikon): Financials
Figure 67 Celartia: Financials
Figure 1 Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 4 Global Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 6 Global Bioprocessing Equipment Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Bioprocessing Equipment Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Bioreactors Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 9 Filtration Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 10 Chromatography Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 11 Cell Culture Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 12 Mixing Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 13 Control & Monitoring Systems Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 14 Others Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 15 Global Bioprocessing Equipment Market Y-o-Y Growth, By Process, 2023-2033 (%)
Figure 16 Upstream Processing Process in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 17 Downstream Processing Process in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 18 Global Bioprocessing Equipment Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 19 Vaccines Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 20 Gene & Cell Therapy Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 21 Monoclonal Antibodies (mAbs) Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 22 Recombinant Proteins Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 23 Others Application in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 24 Global Bioprocessing Equipment Market Y-o-Y Growth, By End User, 2023-2033 (%)
Figure 25 Biopharmaceutical Companies End User in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 26 Contract Manufacturing Organizations (CMOs) End User in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 27 Academic & Research Institutes End User in Global Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 28 Global Bioprocessing Equipment Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 29 North America Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 30 North America Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 31 North America Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 32 North America Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 33 North America Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 34 North America Bioprocessing Equipment Market Share, By Country, 2024 & 2033 (%)
Figure 35 Europe Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 36 Europe Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 37 Europe Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 38 Europe Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 39 Europe Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 40 Europe Bioprocessing Equipment Market Share, By Country, 2024 & 2033 (%)
Figure 41 Asia-Pacific Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 42 Asia-Pacific Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 43 Asia-Pacific Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 44 Asia-Pacific Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 45 Asia-Pacific Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 46 Asia-Pacific Bioprocessing Equipment Market Share, By Country, 2024 & 2033 (%)
Figure 47 South America Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 48 South America Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 49 South America Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 50 South America Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 51 South America Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 52 South America Bioprocessing Equipment Market Share, By Country, 2024 & 2033 (%)
Figure 53 Middle East and Africa Bioprocessing Equipment Market Value, 2022-2033 (US$ Billion)
Figure 54 Middle East and Africa Bioprocessing Equipment Market Share, By Product Type, 2024 & 2033 (%)
Figure 55 Middle East and Africa Bioprocessing Equipment Market Share, By Process, 2024 & 2033 (%)
Figure 56 Middle East and Africa Bioprocessing Equipment Market Share, By Application, 2024 & 2033 (%)
Figure 57 Middle East and Africa Bioprocessing Equipment Market Share, By End User, 2024 & 2033 (%)
Figure 58 Thermo Fisher Scientific, Inc.: Financials
Figure 59 Sartorius AG: Financials
Figure 60 Danaher Corporation (Cytiva): Financials
Figure 61 Merck KGaA: Financials
Figure 62 Eppendorf: Financials
Figure 63 Bionet: Financials
Figure 64 Solaris Biotech: Financials
Figure 65 PBS Biotech, Inc.: Financials
Figure 66 Applikon Biotechnology (Getinge / Applikon): Financials
Figure 67 Celartia: Financials
